发明授权
- 专利标题: Anti-acids secretory recombinant BCG vaccine
- 专利标题(中): 抗分泌重组BCG疫苗
-
申请号: US975699申请日: 1997-11-21
-
公开(公告)号: US5858369A公开(公告)日: 1999-01-12
- 发明人: Kazuhiro Matsuo , Yoshitomo Chujo , Akihiro Yamazaki , Mitsuo Honda , Shudo Yamazaki , Hiromichi Tasaka
- 申请人: Kazuhiro Matsuo , Yoshitomo Chujo , Akihiro Yamazaki , Mitsuo Honda , Shudo Yamazaki , Hiromichi Tasaka
- 申请人地址: JPX Tokyo JPX Tokyo
- 专利权人: Ajinomoto Co., Inc.,Japan as represented by Director General of Agency of National Institute of Health
- 当前专利权人: Ajinomoto Co., Inc.,Japan as represented by Director General of Agency of National Institute of Health
- 当前专利权人地址: JPX Tokyo JPX Tokyo
- 优先权: JPX6-178462 19940729
- 主分类号: A61K39/00
- IPC分类号: A61K39/00 ; A61P31/18 ; C07K14/16 ; C07K14/35 ; C07K14/47 ; A61K38/00 ; A61K39/02 ; C07H21/04
摘要:
A vaccine containing Mycobacterium bovis BCG which secretes a fusion protein to be obtained by inserting a foreign antigen peptide into the molecular surface of a secretory protein, a carrier, having a signal peptide. BCG constituting the present invention secretes a fusion protein to be obtained by inserting a foreign antigen peptide into the molecular surface of an .alpha.-antigen derived from mycobacteria. Said fusion protein has significantly increased antigenicity and immunogenicity. Therefore, when it is inoculated into animals, it is efficiently recognized by B cells which recognize said antigen, thereby effectively inducing the production of an antibody to said antigen. When said BCG itself is inoculated into animals, it continuously secretes said fusion protein in the bodies of the animals while continuously propagating therein. Therefore, said BCG is an extremely useful vaccine.
公开/授权文献
信息查询